Status:
RECRUITING
Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis
Lead Sponsor:
Universität des Saarlandes
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances no...
Detailed Description
Urinary dickkopf-3 (uDKK3), a stress-induced renal tubular epithelium-derived glycoprotein, has been identified as a biomarker predicting persistent kidney dysfunction. In this prospective observatio...
Eligibility Criteria
Inclusion
- Patients treated on the intensive care units of Saarland University Hospital.
Exclusion
- Patients on renal replacement treatment before admission to the intensive care unit.
- Patients with chronic kidney disease stage CKD G3b or below.
- Known kidney disease.
- Kidney transplantation.
- Intoxications leading to dialysis treatment.
- Participation in other clinical trials.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06180551
Start Date
December 1 2023
End Date
June 1 2027
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum des Saarlandes
Homburg, Saarland, Germany, 66421